Low dose oral methotrexate treatment of multiple sclerosis: a pilot study.
- 1 November 1993
- journal article
- clinical trial
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 56 (11) , 1217-1218
- https://doi.org/10.1136/jnnp.56.11.1217
Abstract
An 18-month double-blind treatment of multiple sclerosis with low dose oral methotrexate showed it to be well tolerated and suggested effectiveness in exacerbating-remitting MS but not in the exacerbating progressive and chronic progressive stages.Keywords
This publication has 2 references indexed in Scilit: